Vincent Medical Holdings Limited (HKG:1612)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7100
-0.0050 (-0.70%)
Aug 21, 2026, 3:49 PM HKT

Vincent Medical Holdings Cash Flow Statement

Millions HKD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
104.3869.1757.28-17.460.7
Depreciation & Amortization
34.836.1438.3340.7638.79
Other Amortization
1.950.42-0.21.28
Loss (Gain) From Sale of Assets
---0.45-0.622.26
Asset Writedown & Restructuring Costs
6.561.070.081.010.92
Loss (Gain) From Sale of Investments
-1.151.663.8210.73
Loss (Gain) on Equity Investments
-0.840.33-2.821.665.88
Stock-Based Compensation
0.40.941.882.941.07
Provision & Write-off of Bad Debts
-0.712.611.09-3.29
Other Operating Activities
15.866.037.5935.9112.94
Change in Accounts Receivable
-28.6-16.83-13.018.01-6.38
Change in Inventory
0.27-3.71-8.0414.046.31
Change in Accounts Payable
18.24-17.4317.34-22.78-21.1
Change in Other Net Operating Assets
14.8-6.4224.058.212.38
Operating Cash Flow
167.1273.48124.9875.76119.05
Operating Cash Flow Growth
127.42%-41.20%64.95%-36.36%-42.79%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-113.63-94.47-31.64-18.6-24.96
Sale of Property, Plant & Equipment
--0.64-0.02
Divestitures
----11.78
Sale (Purchase) of Intangibles
-5.99-5.54---
Investment in Securities
--0-0.01-0.01-7.75
Other Investing Activities
1.161.2-31.360.510.38
Investing Cash Flow
-118.46-98.81-62.37-18.1-20.52

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
111.4290.3521.0626.542.46
Long-Term Debt Repaid
-62.03-45.32-55.04-59.21-61.4
Net Debt Issued (Repaid)
49.3945.03-33.97-32.71-18.94
Issuance of Common Stock
4.57--0.214.65
Repurchase of Common Stock
---3.27-2.65-1.62
Common Dividends Paid
-26.45-19.94-8.04-16.35-85.25
Other Financing Activities
-0.171.3-0.08-0.21
Financing Cash Flow
27.3426.39-45.37-67.84-100.95

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.44-3.41-0.8-3.656.52
Net Cash Flow
77.43-2.3416.44-13.834.1

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
53.48-20.9893.3457.1694.1
Free Cash Flow Growth
--63.28%-39.25%-38.21%
Free Cash Flow Margin
5.73%-2.62%13.00%9.09%12.10%
Free Cash Flow Per Share
0.08-0.030.140.090.14
Levered Free Cash Flow
51.8-0.7781.5586.7558.07
Unlevered Free Cash Flow
52.360.0882.688.5459.59

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.361.51.682.852.43
Cash Income Tax Paid
16.111.895.923.229.45
Change in Working Capital
4.72-44.3920.357.49-18.78